Provided by Tiger Trade Technology Pte. Ltd.

Nasdaq

93.65
+1.281.39%
Post-market: 93.07-0.5798-0.62%19:49 EDT
Volume:1.83M
Turnover:171.25M
Market Cap:52.35B
PE:27.31
High:93.95
Open:92.50
Low:92.50
Close:92.37
52wk High:101.79
52wk Low:76.55
Shares:559.00M
Float Shares:496.00M
Volume Ratio:0.56
T/O Rate:0.37%
Dividend:1.12
Dividend Rate:1.20%
EPS(TTM):3.43
EPS(LYR):3.09
ROE:16.52%
ROA:5.85%
PB:4.37
PE(LYR):30.31

Loading ...

Fnac Darty Reports 29,682,146 Shares, 29,369,800 Net Voting Rights as of Sept. 30, 2026

Reuters
·
Oct 02

Signaux Girod Reports 1,032,500 Issued Shares as of Sept. 30, 2026

Reuters
·
Oct 02

NASDAQ New 52-Week Highs and Lows

Dow Jones
·
Oct 02

Biogen Says Litifilimab Posts Sustained Skin Clearance in 52-Week Phase 2 Cutaneous Lupus Study

Reuters
·
Oct 02

Goldman Sachs Voting Rights in Netcompany Rise to 5.70% from 3.47%

Reuters
·
Oct 02

MT Højgaard Unit Enemærke & Petersen Wins DKK 665 Million Taastrupgaard Refurbishment Contract

Reuters
·
Oct 02

ChemoMetec Completes DKK 100 Million Share Buyback Program, Repurchases 239,950 Shares

Reuters
·
Oct 02

Crispr Therapeutics Presents Phase 1 Zugo-Cel Data in Refractory Systemic Sclerosis at ACR Convergence 2026

Reuters
·
Oct 02

SeaStar Medical to Present SAVE Registry Data on SCD-PED Outcomes in Pediatric Sepsis-Associated AKI at ASN Kidney Week 2026

Reuters
·
Oct 02

YYForce Deploys Hospitality Service Robot at Aloft Langkawi Pantai Tengah in Malaysia

Reuters
·
Oct 02

Climb Bio to Present Preliminary Phase 2 PrisMN Trial Data for Budoprutug in Primary Membranous Nephropathy at ASN Kidney Week 2026

Reuters
·
Oct 02

Matador Technologies Calls Shareholder Meeting

Reuters
·
Oct 02

Newcleo Names Ex-TVA Chief Jeffrey Lyash Board Chairman

Reuters
·
Oct 02

Vera Therapeutics Says Origin 3 Final Efficacy Data for Trutakna in IgA Nephropathy is Set for Late-Breaking ASN Kidney Week 2026 Talk

Reuters
·
Oct 02

Decent Holding Prices Private Placement of Unregistered Warrants for 822,828 Shares at $1.50 Each

Reuters
·
Oct 02

Christian Dior Reports 180,507,516 Issued Shares as of Sept. 30, 2026

Reuters
·
Oct 02

Artiva Biotherapeutics Posts Updated Phase 2a AlloNK Plus Rituximab Data in Refractory Rheumatoid Arthritis at ACR 2026

Reuters
·
Oct 02

iTonic Holdings Announces 16-for-1 Share Consolidation Effective Oct. 6

Reuters
·
Oct 02

Immuneering Plans Phase 2 Trial of Atebimetinib Plus PD-1 Blockade in Lung Cancer Patients

Reuters
·
Oct 02

ATA Creativity Global Gets NASDAQ Notice After ADS Bid Price Stays Below $1

Reuters
·
Oct 02